Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G S M Ramsaransing

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Acta Neurologica Scandinavica|May 6, 2006
Benign course in multiple sclerosis: a reviewG S M Ramsaransing, J De Keyser
European Journal of Neurology|July 31, 2007
Predictive value of clinical characteristics for 'benign' multiple sclerosisG S M Ramsaransing, J De Keyser
European Journal of Neurology|June 17, 2005
Serum uric acid, dehydroepiandrosterone sulphate, and apolipoprotein E genotype in benign vs. progressive multiple sclerosisG S M Ramsaransing, D J Heersema, J De Keyser
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005
Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and primary progressive multiple sclerosisN Wilczak, G S M Ramsaransing, J Mostert, et al.
European Journal of Neurology|October 25, 2007
Relationship between the extent of T2 lesions and the onset of secondary progression in multiple sclerosisJ P Mostert, J C de Groot, G S M Ramsaransing, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2006
Plasma homocysteine levels in multiple sclerosisG S M Ramsaransing, M R Fokkema, A Teelken, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Acta Neurologica Scandinavica|May 6, 2006
Benign course in multiple sclerosis: a reviewG S M Ramsaransing, J De Keyser
European Journal of Neurology|July 31, 2007
Predictive value of clinical characteristics for 'benign' multiple sclerosisG S M Ramsaransing, J De Keyser
European Journal of Neurology|June 17, 2005
Serum uric acid, dehydroepiandrosterone sulphate, and apolipoprotein E genotype in benign vs. progressive multiple sclerosisG S M Ramsaransing, D J Heersema, J De Keyser
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005
Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and primary progressive multiple sclerosisN Wilczak, G S M Ramsaransing, J Mostert, et al.
European Journal of Neurology|October 25, 2007
Relationship between the extent of T2 lesions and the onset of secondary progression in multiple sclerosisJ P Mostert, J C de Groot, G S M Ramsaransing, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2006
Plasma homocysteine levels in multiple sclerosisG S M Ramsaransing, M R Fokkema, A Teelken, et al.
Pageof 1